We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

603501:SSEOmniVision Integrated Circuits Group, Inc. Class A Analysis

Data as of 2026-03-14 - not real-time

CN¥111.73

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at CNY 111.73, comfortably below its 20‑day (CNY 116.24), 50‑day (CNY 122.56) and 200‑day (CNY 127.04) simple moving averages, a classic bearish signal. The MACD line sits at –2.60 beneath its signal at –2.38 with a negative histogram, while the RSI of 36 hints at a near‑oversold condition but not yet a clear reversal. Price is perched just above the identified support of CNY 110.56 and far under the resistance at CNY 124.20, suggesting limited upside in the short run.
Fundamentally, OmniVision delivers solid top‑line growth (revenue up 14.8%) and healthy operating margins (18.5%), with ROE at 16.3% and a modest dividend payout ratio of 12% supporting a sustainable yield of 0.55%. Nonetheless, the market assigns a trailing P/E of 32.3 versus an industry average of 33.7, and a DCF‑derived fair value near CNY 9 signals severe overvaluation. The balance sheet shows a debt‑to‑equity of 39.3% offset by ample cash (CNY 11.8 B), while volatility is high at 29% and beta is low (~0.10), indicating price swings are largely company‑specific.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below all major moving averages
  • Bearish MACD divergence
  • Proximity to support level with limited upside

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong revenue growth and operating margins
  • Sustainable dividend with low payout ratio
  • Elevated volatility and sector headwinds

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Fundamental growth trajectory and solid cash position
  • Potential price correction towards intrinsic value
  • Long‑term demand for semiconductor sensors across multiple end‑markets

Key Metrics & Analysis

Financial Health

Revenue Growth14.80%
Profit Margin14.54%
P/E Ratio32.3
ROE16.34%
ROA6.24%
Debt/Equity39.26
P/B Ratio4.9
Op. Cash FlowCN¥4.2B
Free Cash FlowCN¥412.5M
Industry P/E33.7

Technical Analysis

TrendBearish
RSI36.3
SupportCN¥110.56
ResistanceCN¥124.20
MA 20CN¥116.24
MA 50CN¥122.56
MA 200CN¥127.04
MACDBearish
VolumeStable
Fear & Greed Index72.88

Valuation

Fair ValueCN¥8.95
GradeOvervalued
TypeGrowth
Dividend Yield0.55%

Risk Assessment

Beta0.10
Volatility29.32%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.